T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.

T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.

T-cell vaccination (TCV) for multiple sclerosis (MS) refers to treatment with autologous anti-myelin T-cells, attenuated by irradiation. Previously published clinical trials have been all open-labeled.To evaluate the safety and efficacy of TCV in progressive MS, in a double-blind, controlled clinica...

Full description

Bibliographic Details
Main Authors: Dimitrios Karussis, Hagai Shor, Julia Yachnin, Naama Lanxner, Merav Amiel, Keren Baruch, Yael Keren-Zur, Ofra Haviv, Massimo Filippi, Panayiota Petrou, Shalom Hajag, Urania Vourka-Karussis, Adi Vaknin-Dembinsky, Salim Khoury, Oded Abramsky, Henri Atlan, Irun R Cohen, Rivka Abulafia-Lapid
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3522721?pdf=render

Internet

http://europepmc.org/articles/PMC3522721?pdf=render

Similar Items